Drug Susceptibility Testing of Anaerobic Protozoa
暂无分享,去创建一个
[1] P. Upcroft,et al. Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa , 2001, Clinical Microbiology Reviews.
[2] J. Ballet,et al. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. , 2000, The Journal of antimicrobial chemotherapy.
[3] J. Zalcberg,et al. MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines , 2000, Prostate Cancer and Prostatic Diseases.
[4] D. Monnet. Toward multinational antimicrobial resistance surveillance systems in Europe. , 2000, International journal of antimicrobial agents.
[5] Hand Wl. Current challenges in antibiotic resistance. , 2000 .
[6] P. Upcroft,et al. Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. , 2000, Molecular and biochemical parasitology.
[7] J. Cohen. AIDS Researchers Look to Africa for New Insights , 2000, Science.
[8] R. Furneaux,et al. Trichomonas vaginalis: detection of nucleoside hydrolase activity as a potential screening procedure. , 2000, Experimental parasitology.
[9] T. Meri,et al. Resistance of Trichomonas vaginalis to Metronidazole: Report of the First Three Cases from Finland and Optimization of In Vitro Susceptibility Testing under Various Oxygen Concentrations , 2000, Journal of Clinical Microbiology.
[10] M. Viikki. Gynaecological Infections as Risk Determinants of Subsequent Cervical Neoplasia , 2000, Acta oncologica.
[11] W. L. Hand,et al. Current challenges in antibiotic resistance. , 2000, Adolescent medicine.
[12] G. Garnett,et al. Why is Trichomonas vaginalis ignored? , 1999, Sexually transmitted infections.
[13] D. A. Wachter,et al. Antibiotic dispensing by drug retailers in Kathmandu, Nepal , 1999, Tropical medicine & international health : TM & IH.
[14] E. Tannich,et al. Metronidazole Resistance in the Protozoan Parasite Entamoeba histolytica Is Associated with Increased Expression of Iron-containing Superoxide Dismutase and Peroxiredoxin and Decreased Expression of Ferredoxin 1 and Flavin Reductase* , 1999, The Journal of Biological Chemistry.
[15] P. Nyirjesy,et al. Metronidazole-resistant vaginal trichomoniasis--an emerging problem. , 1999, The New England journal of medicine.
[16] P. Upcroft,et al. Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis. , 1999, Molecular and biochemical parasitology.
[17] P. Upcroft,et al. Efficacy of New 5-Nitroimidazoles against Metronidazole-Susceptible and -Resistant Giardia,Trichomonas, and Entamoeba spp , 1999, Antimicrobial Agents and Chemotherapy.
[18] D. Warhurst. Drug resistance inPlasmodium falciparum malaria , 1999 .
[19] D. Warhurst. Drug resistance in Plasmodium falciparum malaria. , 1999, Infection.
[20] Joanne E. Harvey,et al. A novel and simple colorimetric method for screening Giardia intestinalis and anti-giardial activity in vitro , 1998, Parasitology.
[21] Myron S. Cohen,et al. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis , 1998, The Lancet.
[22] A. Banner. Non-steroidal anti-inflammatory therapy for bronchial asthma , 1998, The Lancet.
[23] David M Brown,et al. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. , 1997, The Journal of antimicrobial chemotherapy.
[24] K. Lamp,et al. Metronidazole. A therapeutic review and update. , 1997, Drugs.
[25] W. Mccormack,et al. Trichomoniasis in pregnancy. , 1997, Sexually transmitted diseases.
[26] P. Upcroft,et al. Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. , 1996, Molecular and biochemical parasitology.
[27] P. Upcroft,et al. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin. , 1996, Microbial drug resistance.
[28] R. Shepherd,et al. Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. , 1995, Acta tropica.
[29] L. Ortiz‐Ortiz,et al. Seroepidemiology of amebiasis in Mexico. , 1994, The American journal of tropical medicine and hygiene.
[30] M. Farthing. Pathogenesis of giardiasis , 1993 .
[31] P. Boreham,et al. Metronidazole resistant Trichomonas vaginalis in Brisbane , 1993, The Medical journal of Australia.
[32] S. Tharavaníj,et al. Axenic cultivation of Entamoeba histolytica from liver abscess and its zymodeme. , 1993, The Southeast Asian journal of tropical medicine and public health.
[33] J. Tachezy,et al. In Vitro Induced Anaerobic Resistance to Metronidazole In Trichomonas Vaginalis , 1993, The Journal of eukaryotic microbiology.
[34] P. Upcroft,et al. Drug resistance and Giardia. , 1993, Parasitology today.
[35] A. Hall,et al. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] R. Hibbs. Diarrhoeal disease: current concepts and future challenges. Introduction. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[37] R. C. Thompson,et al. Giardia and giardiasis. , 1993, Advances in parasitology.
[38] S. Piscitelli,et al. Clinical Pharmacokinetics of Metronidazole and Other Nitroimidazole Anti-Infectives , 1992, Clinical pharmacokinetics.
[39] P. Upcroft,et al. Induction of metronidazole and furazolidone resistance in Giardia. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[40] T. Edlind,et al. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro. , 1990, The Journal of infectious diseases.
[41] Miklós Müller. Biochemistry of Trichomonas vaginalis , 1990 .
[42] G. Burchard,et al. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. , 1988, Experimental parasitology.
[43] R. Shepherd,et al. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[44] R. Shepherd,et al. The sensitivity of Giardia intestinalis to drugs in vitro. , 1984, The Journal of antimicrobial chemotherapy.
[45] F. Gillin. The Role of Reducing Agents and the Physiology of Trophozoite Attachment , 1984 .
[46] M. Müller,et al. Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities , 1983, Antimicrobial Agents and Chemotherapy.
[47] D. Keister. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[48] L S Diamond,et al. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[49] O. Jírovec,et al. Trichomonas vaginalis and trichomoniasis. , 1968, Advances in parasitology.
[50] R. Trussell,et al. Triehomonas vaginalis and trichomoniasis. , 1947 .